STOCK TITAN

Seven Fleet group beneficially owns 1,085,398 CTMX shares (NASDAQ: CTMX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CytomX Therapeutics ownership disclosure: Seven Fleet Master Fund and related reporting persons report beneficial ownership of 1,085,398 shares of Common Stock, representing 0.5% of the class.

The filing states the 217,702,919 shares outstanding as of April 30, 2026 were reported in the issuer's Form 10-Q filed May 7, 2026. The statement also notes that Longitude may be deemed to beneficially own 15,288,461 shares (7.0%) based on information provided to the reporting persons; the reporting persons disclaim group membership.

Positive

  • None.

Negative

  • None.

Insights

Disclosure shows a small passive stake by Seven Fleet and a larger reported interest tied to Longitude.

The schedule reports 1,085,398 shares for Seven Fleet entities, equal to 0.5% of the issuer's 217,702,919 shares outstanding as of April 30, 2026. The filing is a Section 13G/A ownership update and reflects beneficial‑ownership reporting rather than active trading.

Impact depends on holder decisions; subsequent filings would show any change. Timing and cash‑flow treatment are not stated in the provided excerpt.

Filing emphasizes attribution through investment-management entities and a disclaimer of group membership.

The cover notes that Seven Fleet Management, Seven Fleet Management GP and Dr. Brian Liu may be deemed to beneficially own shares held of record by Seven Fleet Master Fund. The Schedule also references potential group ties to Longitude, which the reporting persons disclaim.

Investors should note the filing is informational; any change in voting or disposition power would require future disclosure.

Seven Fleet shares beneficially owned 1,085,398 shares Reported in Schedule 13G/A amendment
Percent of class (Seven Fleet) 0.5% Based on 217,702,919 shares outstanding as reported
Shares outstanding 217,702,919 shares Outstanding as of <date>April 30, 2026</date> per issuer Form 10-Q
Longitude deemed beneficial ownership 15,288,461 shares Reported as potentially beneficially owned by Longitude per information provided
Percent of class (Longitude) 7.0% Based on issuer's reported outstanding shares in Form 10-Q
beneficially own regulatory
"Seven Fleet Master Fund is the record owner of 1,085,398 shares of Common Stock"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Schedule 13G/A regulatory
"This joint statement on is being filed by Seven Fleet Master Fund LP"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Section 13(d)(3) regulatory
"may be deemed to be members of a group within the meaning of Section 13(d)(3) of the Securities Exchange Act"
shared dispositive power financial
"Shared Dispositive Power 1,085,398.00"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





23284F105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Rows 6, 8 and 9: All such shares are held of record by Seven Fleet Master Fund (as defined in Item 2(a) below). Seven Fleet Management, as the investment manager of Seven Fleet Master Fund, may be deemed to beneficially own the shares of Common Stock held directly by Seven Fleet Master Fund. Seven Fleet Management GP, as the general partner of Seven Fleet Management, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management. The Reporting Individual, as the managing member of Seven Fleet Management GP, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management GP. Note to Row 11: Based on 217,702,919 shares of Common Stock (as defined in Item 2(d) below) outstanding as of April 30, 2026 reported by the Issuer (as defined in Item 1(a) below) in its Quarterly Report on Form 10-Q dated and filed with the Securities and Exchange Commission (the "Commission") May 7, 2026 (the "Quarterly Report").


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Rows 6, 8 and 9: All such shares are held of record by Seven Fleet Master Fund. Seven Fleet Management, as the investment manager of Seven Fleet Master Fund, may be deemed to beneficially own the shares of Common Stock held directly by Seven Fleet Master Fund. Seven Fleet Management GP, as the general partner of Seven Fleet Management, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management. The Reporting Individual, as the managing member of Seven Fleet Management GP, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management GP. Note to Row 11: Based on 217,702,919 shares of Common Stock outstanding as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Rows 6, 8 and 9: All such shares are held of record by Seven Fleet Master Fund. Seven Fleet Management, as the investment manager of Seven Fleet Master Fund, may be deemed to beneficially own the shares of Common Stock held directly by Seven Fleet Master Fund. Seven Fleet Management GP, as the general partner of Seven Fleet Management, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management. The Reporting Individual, as the managing member of Seven Fleet Management GP, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management GP. Note to Row 11: Based on 217,702,919 shares of Common Stock outstanding as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Note to Rows 6, 8 and 9: All such shares are held of record by Seven Fleet Master Fund. Seven Fleet Management, as the investment manager of Seven Fleet Master Fund, may be deemed to beneficially own the shares of Common Stock held directly by Seven Fleet Master Fund. Seven Fleet Management GP, as the general partner of Seven Fleet Management, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management. The Reporting Individual, as the managing member of Seven Fleet Management GP, may be deemed to beneficially own the shares of Common Stock beneficially owned by Seven Fleet Management GP. Note to Row 11: Based on 217,702,919 shares of Common Stock outstanding as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2026.


SCHEDULE 13G



Seven Fleet Master Fund LP
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu, Managing Member of Seven Fleet Capital Management LP, its Investment Mgr and Seven Fleet Capital Management GP, LLC, its Gen'l Ptr
Date:05/15/2026
Seven Fleet Capital Management LP
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu , Managing Member of Seven Fleet Capital Management GP, LLC, its General Partner
Date:05/15/2026
Seven Fleet Capital Management GP LLC
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu, Managing Member
Date:05/15/2026
Brian Liu
Signature:/s/ Dr. Brian Liu
Name/Title:Dr. Brian Liu
Date:05/15/2026

FAQ

What stake does Seven Fleet report in CTMX?

Seven Fleet reports beneficial ownership of 1,085,398 shares of Common Stock, representing 0.5% of the class based on the issuer's stated outstanding share count. This figure is recorded in the Schedule 13G/A filed as an amendment.

How many CTMX shares were outstanding for the percentage calculation?

The filing cites 217,702,919 shares outstanding as of April 30, 2026, reported in the issuer's Form 10-Q filed May 7, 2026. That outstanding share count is used to calculate the 0.5% stake reported for Seven Fleet.

Does the filing show a group affiliation with Longitude for CTMX holdings?

The Schedule states Longitude may be deemed to beneficially own 15,288,461 shares (7.0%) based on information provided; however, the Reporting Persons expressly disclaim group membership and beneficial ownership arising from such arrangements.

Who are the reporting persons named in the CTMX filing?

The filing is by Seven Fleet Master Fund LP, Seven Fleet Capital Management LP, Seven Fleet Capital Management GP LLC and Dr. Brian Liu (the Reporting Individual). The principal business address is listed as Mountain View, California.

Does the filing state who holds voting or dispositive power over the 1,085,398 CTMX shares?

The cover rows show 0 sole voting and dispositive power and 1,085,398 shared voting and dispositive power for the listed reporting persons, with explanatory footnotes tying record ownership to Seven Fleet Master Fund.